PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34337080-0	2021	Exosomes Derived from Nerve Stem Cells Loaded with FTY720 Promote the Recovery after Spinal Cord Injury in Rats by PTEN/AKT Signal Pathway.	Fingolimod Hydrochloride	51-57	AKT serine/threonine kinase 1	Rattus norvegicus	120-123	
28054340-11	2017	Fingolimod treatment improved functional and morphological outcomes after GMH, in part, by tempering acute post-hemorrhagic blood-brain barrier disruption via the activation of the S1PR1/Akt/Rac1 pathway.	Fingolimod Hydrochloride	0-10	AKT serine/threonine kinase 1	Rattus norvegicus	187-190	
35274449-0	2022	Fingolimod ameliorates acetic acid-induced ulcerative colitis: An insight into its modulatory impact on pro/anti-inflammatory cytokines and AKT/mTOR signalling.	Fingolimod Hydrochloride	0-10	AKT serine/threonine kinase 1	Rattus norvegicus	140-143	
35274449-1	2022	BACKGROUND: Because of the approved immunomodulatory activities of fingolimod, the current study aimed at studying the curative potential of fingolimod against experimentally induced ulcerative colitis (UC) via modulating pro/anti-inflammatory cytokines release and AKT/mTOR signalling.	Fingolimod Hydrochloride	141-151	AKT serine/threonine kinase 1	Rattus norvegicus	266-269	
35274449-10	2022	In addition, fingolimod decreased the expressions of AKT and mTOR compared to the UC group.	Fingolimod Hydrochloride	13-23	AKT serine/threonine kinase 1	Rattus norvegicus	53-56	
35274449-11	2022	CONCLUSION: Fingolimod attenuated acetic acid-induced UC through its immunomodulatory effect by shifting the balance to favour anti-inflammatory cytokine production rather than pro-inflammatory cytokines and modulating the AKT/mTOR signalling.	Fingolimod Hydrochloride	12-22	AKT serine/threonine kinase 1	Rattus norvegicus	223-226